GlassScriptPhysician profile
Michael A Doughty
NPI 1588630750
$525.60
in general payments reported to CMS, 2019-2025
9 companies · $37.28 in 2025
The $37.28 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $123 · 2023: $90.87 · 2024: $275 · 2025: $37.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $403.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $402.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $102.77 | 2024 | |
| Nevro Corp. | $77.68 | 2022-2024 | Senza |
| Horizon Therapeutics Plc | $76.94 | 2022-2023 | Krystexxa |
| Amgen INC. | $76.80 | 2024-2025 | Krystexxa |
| Melinta Therapeutics, LLC | $67.00 | 2022 | |
| Paratek Pharmaceuticals, INC. | $63.07 | 2023-2024 | Nuzyra |
| Organogenesis INC. | $31.32 | 2024 | Apligraf |
| International Rehabilitative Sciences, INC | $15.29 | 2024 | Rs 4i Plus Sequential Stimulator |
| Smith+Nephew, INC. | $14.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Doughty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.